ArticleLeukemia2024

Genomic DNA-based measurable residual disease monitoring in pediatric acute myeloid leukemia: unselected consecutive cohort study.

Marketa Zaliova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.